Technology | July 14, 2009

M. D. Anderson Installs Optical Noise-Canceling System for Interventional MRI

July 14, 2009 –The University of Texas M. D. Anderson Cancer Center (MDACC) has installed in its clinical interventional MRI suite the IMROC communication system, a fiber optics-based system that enables doctors to converse normally in the noisy MRI environment.

Optoacoustics’ Interventional MR Optical Communication System (IMROC) is designed to enable doctors in interventional MRI (iMRI) environments to work smoothly and quietly during procedures, speaking freely with both technicians and patients.

Designed for today's advanced MRI suites, IMROC supports up to eight concurrent
dialogs, eliminating MRI acoustic gradient noise and providing previously unheard voice quality.

The IMROC system comprises Optoacoustics’ FOMRI highly directional fiber optical microphone integrated with new, patented fiber optical headphones, an optics-based switching unit worn by staff members in the scanner room, and a six-channel mixing and control console that resides in the MRI control room. IMROC is completely EMI/RFI immune and has been proven safe for MRI environments.

The IMROC system combines multi-disciplinary breakthroughs such as optoacoustic
MEMS transducers developed specifically for high-field MRI environments, together with state-of-the-art digital signal processing. IMROC provides multi-channel adaptive noise reduction and echo cancellation to bring hands-free, full duplex communications between MRI scanner and control rooms.

M. D. Anderson’s pioneering iMRI activities currently focus on MR-guided biopsies and ablations for soft tissue and for the head, neck, bone, liver and kidney. For biopsies, the
MDACC staff has begun using two IMROC headsets (radiologist and control room technologist); for ablations, up to three headsets (radiologist, staff and technologist); for combined MR and fluoroscopy procedures, as many as five IMROC staff headsets are used.

For more information: www.optoacoustics.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...